Michael Boxberger

1.4k total citations
21 papers, 999 citations indexed

About

Michael Boxberger is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Boxberger has authored 21 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 15 papers in Cardiology and Cardiovascular Medicine and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Boxberger's work include Coronary Interventions and Diagnostics (20 papers), Cardiac Imaging and Diagnostics (14 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Michael Boxberger is often cited by papers focused on Coronary Interventions and Diagnostics (20 papers), Cardiac Imaging and Diagnostics (14 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Michael Boxberger collaborates with scholars based in Germany, Malaysia and United States. Michael Boxberger's co-authors include Franz X. Kleber, Ralf Degenhardt, Bruno Scheller, Martin Unverdorben, Hanns Ackermann, C. Vallbracht, Bodo Cremers, Matthias Leschke, Wolfgang Bocksch and Detlef G. Mathey and has published in prestigious journals such as Circulation, Diabetes Care and Catheterization and Cardiovascular Interventions.

In The Last Decade

Michael Boxberger

21 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Boxberger Germany	12	958	603	479	352	26	21	999
Patrick Serruys Netherlands	11	798 0.8×	575 1.0×	559 1.2×	254 0.7×	20 0.8×	14	966
Javier Zueco Spain	19	804 0.8×	718 1.2×	379 0.8×	336 1.0×	20 0.8×	70	1.1k
Marco Bressers Netherlands	13	797 0.8×	597 1.0×	391 0.8×	274 0.8×	22 0.8×	16	887
Matthias Waliszewski Germany	13	905 0.9×	524 0.9×	378 0.8×	384 1.1×	23 0.9×	57	965
Kenneth M. Kent United States	13	920 1.0×	528 0.9×	565 1.2×	339 1.0×	34 1.3×	20	1.0k
Lowell F. Satler United States	17	1.1k 1.1×	648 1.1×	617 1.3×	388 1.1×	43 1.7×	24	1.2k
Simonetta Blengino Italy	14	848 0.9×	735 1.2×	380 0.8×	284 0.8×	13 0.5×	36	1.0k
Diethmar Antoni Germany	9	712 0.7×	567 0.9×	322 0.7×	330 0.9×	24 0.9×	23	889
Kenneth Tandjung Netherlands	15	860 0.9×	680 1.1×	259 0.5×	284 0.8×	10 0.4×	33	962
Gary S. Mintz United States	14	877 0.9×	527 0.9×	532 1.1×	360 1.0×	44 1.7×	21	982

Countries citing papers authored by Michael Boxberger

Since Specialization

Citations

This map shows the geographic impact of Michael Boxberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Boxberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Boxberger more than expected).

Fields of papers citing papers by Michael Boxberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Boxberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Boxberger. The network helps show where Michael Boxberger may publish in the future.

Co-authorship network of co-authors of Michael Boxberger

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Boxberger. A scholar is included among the top collaborators of Michael Boxberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Boxberger. Michael Boxberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krackhardt, Florian, Matthias Waliszewski, Christophe Piot, et al.. (2018). Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT). Herz. 44(5). 433–439. 4 indexed citations

Zuhdi, Ahmad Syadi Mahmood, Florian Krackhardt, Matthias Waliszewski, et al.. (2018). Efficacy and Safety of Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents for Chronic Total Occlusions: Insights from the Coroflex ISAR 2000 Worldwide Registry. Cardiology Research and Practice. 2018. 1–7. 4 indexed citations

Krackhardt, Florian, Viktor Kočka, Matthias Waliszewski, et al.. (2017). Polymer-free sirolimus-eluting stents in a large-scale all-comers population. Open Heart. 4(2). e000592–e000592. 12 indexed citations

Ismail, Muhammad Dzafir, Wan Azman Wan Ahmad, Matthias Leschke, et al.. (2016). The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study. SpringerPlus. 5(1). 1668–1668. 6 indexed citations

Zuhdi, Ahmad Syadi Mahmood, Uwe Zeymer, Matthias Waliszewski, et al.. (2016). The use of paclitaxel coated balloon (PCB) in acute coronary syndrome of small vessel de novo lesions: an analysis of a prospective ‘real world’ registry. SpringerPlus. 5(1). 373–373. 5 indexed citations

Kleber, Franz X., Harald Rittger, Josef Ludwig, et al.. (2016). Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clinical Research in Cardiology. 105(7). 613–621. 101 indexed citations

Unverdorben, Martin, C. Vallbracht, Bodo Cremers, et al.. (2015). Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention. 11(8). 926–934. 66 indexed citations

Żurakowski, Aleksander, Piotr Buszman, Krzysztof Milewski, et al.. (2015). Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial. Journal of Interventional Cardiology. 28(4). 348–357. 18 indexed citations

Unverdorben, Martin, Franz X. Kleber, Hans‐Reiner Figulla, et al.. (2013). Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?. EuroIntervention. 9(5). 620–628. 67 indexed citations

10.

Kaul, Upendra, Martin Unverdorben, Ralf Degenhardt, et al.. (2013). The Paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: An angiographic follow up study. Indian Heart Journal. 65(5). 510–517. 11 indexed citations

11.

Degenhardt, Ralf, Robaayah Zambahari, Damras Tresukosol, et al.. (2011). Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention. 7(K). K83–K92. 58 indexed citations

12.

Mathey, Detlef G., et al.. (2011). Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention. 7(K). K61–K65. 91 indexed citations

13.

Unverdorben, Martin, Franz X. Kleber, Hans‐Reiner Figulla, et al.. (2010). Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clinical Research in Cardiology. 99(3). 165–174. 130 indexed citations

14.

Wiemer, Marcus, Ralf Degenhardt, C. Vallbracht, et al.. (2010). The Paclitaxel‐Eluting Coroflex™ Stent Study II (PECOPS II) Acute and 6‐Month Clinical and Angiographic Follow‐Up, 1‐Year Clinical Follow‐Up. Journal of Interventional Cardiology. 23(2). 160–166. 5 indexed citations

15.

Unverdorben, Martin, C. Vallbracht, Bodo Cremers, et al.. (2009). Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis. Circulation. 119(23). 2986–2994. 367 indexed citations

16.

Unverdorben, Martin, Ralf Degenhardt, Marcus Wiemer, et al.. (2009). The paclitaxel‐eluting coroflex™ please stent study (PECOPS I): The 3‐year clinical follow‐up. Catheterization and Cardiovascular Interventions. 74(5). 674–682. 4 indexed citations

17.

Scheller, Bruno, et al.. (2007). Short- and long-term effects of a novel paclitaxel coated stent in the porcine coronary model. Clinical Research in Cardiology. 97(2). 118–123. 12 indexed citations

18.

Unverdorben, Martin, Ralf Degenhardt, Marcus Wiemer, et al.. (2007). The Paclitaxel-Eluting Coroflex™ Please Stent Pilot Study (PECOPS I). Clinical Research in Cardiology. 96(11). 803–811. 10 indexed citations

19.

Unverdorben, Martin, Ralf Degenhardt, C. Vallbracht, et al.. (2006). The paclitaxel‐eluting Coroflex™ please stent pilot study (PECOPS I): Acute and 6‐month clinical and angiographic follow‐up. Catheterization and Cardiovascular Interventions. 67(5). 703–710. 12 indexed citations

20.

Chantelau, E., et al.. (1987). Interaction Between Plastic Catheter Tubings and Regular Insulin Preparations Used for Continuous Subcutaneous Insulin-Infusion Therapy. Diabetes Care. 10(3). 348–351. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact